drugset / Trial / NCT04069325
Efficacy and Safety of Simiaowan in Prevention of Acute Flares in Chronic Gout Patients Initiating Febuxostat Therapy
Unknown
72 enrolled
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Affiliated Hospital of Nanjing University of Chinese Medicine · collabThe Second Affiliated Hospital of Dalian Medical University · collab
RandomizedParallel-groupTriple-blindPrevention
Summary
The aim of this study is to evaluate the efficacy and safety of simiaowan in prevention of acute flares in chronic gout patients initiating febuxostat therapy.
Timeline
- Start
- 2019-09-01
- Primary completion
- 2020-07-28
- Completion
- 2020-07-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | simiaowan | Unknown | 6 g | Oral |
| Background | Febuxostat | Small molecule | 40 mg | Oral |